| Website | aureon.com |
| Category | BioTech |
| Employees | |
| Description | Cancer diagnotics |
| TOTAL | $7M |
| FUNDING TOTAL | $7M |
| Series D, 4/10 Atlas Venture New Leaf Venture Partners Sprout Group Pfizer | $7M |
Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.
